Sign in to fuzzto save your conversations, follow your research and come back anytime.
Q-Line Biotech
SectorHealthcare
| Metric (₹ crore) | Q3 FY26 | Q4 FY26 |
|---|---|---|
| Sales | 88.62 | 109.32 |
| Expenses | 59.49 | 76.37 |
| EBITDA | 29.13 | 32.95 |
| Depreciation | 2.21 | 4.49 |
| EBIT | 26.92 | 28.46 |
| Interest | 5.03 | 6.08 |
| Profit Before Tax | 21.89 | 22.38 |
| Net Profit | 17.38 | 17.03 |
| EPS | 10.68 | 10.46 |
| Metric (₹ crore) | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Operating Cash Flow | 24.97 | -24.18 | 17.21 | 16.38 |
| Investing Cash Flow | -26.31 | -44.69 | -77.47 | -29.42 |
| Financing Cash Flow | 26.4 | 16.99 | 53.18 | 41.64 |
| Net Cash Flow | 25.06 | -51.88 | -7.08 | 28.6 |
| Metric (₹ crore) | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Equity / Shareholders' Funds | 127.36 | 161.81 | 189.95 | 246.19 |
| Total Liabilities | 124.21 | 177.43 | 265.54 | 312.49 |
| Total Assets | 251.58 | 339.25 | 455.5 | 558.69 |